45 related articles for article (PubMed ID: 22741047)
21. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model.
Xiao Z; McCallum TJ; Brown KM; Miller GG; Halls SB; Parney I; Moore RB
Br J Cancer; 1999 Oct; 81(4):638-46. PubMed ID: 10574249
[TBL] [Abstract][Full Text] [Related]
22. Optimizing syngeneic orthotopic murine bladder cancer (MB49).
Günther JH; Jurczok A; Wulf T; Brandau S; Deinert I; Jocham D; Böhle A
Cancer Res; 1999 Jun; 59(12):2834-7. PubMed ID: 10383142
[TBL] [Abstract][Full Text] [Related]
23. Development of secondary structure, growth characteristics and cytogenetic analysis of human transitional cell carcinoma xenografts in scid/scid mice.
McCue PA; Gomella LG; Veltri RW; Marley GM; Miller MC; Lattime EC
J Urol; 1996 Mar; 155(3):1128-32. PubMed ID: 8583578
[TBL] [Abstract][Full Text] [Related]
24. Impairment of antibacterial effect of bladder surface mucin by protamine sulfate.
Parsons CL; Stauffer C; Schmidt JD
J Infect Dis; 1981 Aug; 144(2):180. PubMed ID: 7276632
[No Abstract] [Full Text] [Related]
25. Technical factors affecting the reproducibility of intravesical mouse bladder tumor implantation during therapy with Bacillus Calmette-Guérin.
Shapiro A; Kelley DR; Oakley DM; Catalona WJ; Ratliff TL
Cancer Res; 1984 Jul; 44(7):3051-4. PubMed ID: 6373001
[TBL] [Abstract][Full Text] [Related]
26. The production of carcinoma of the urinary bladder in rats by feeding N-[3-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Ertürk E; Price JM; Morris JE; Cohen S; Leith RS; Von Esch AM; Crovetti AJ
Cancer Res; 1967 Nov; 27(11):1998-2002. PubMed ID: 6073497
[No Abstract] [Full Text] [Related]
27. Pathogenesis, histology, and transplantability of urinary bladder carcinomas induced in albino rats by oral administration of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.
Ertürk E; Cohen SM; Price JM; Bryan GT
Cancer Res; 1969 Dec; 29(12):2219-28. PubMed ID: 5387262
[No Abstract] [Full Text] [Related]
28. Antiproliferative and immunomodulatory actions of beta-interferon and double-stranded RNA, individually and in combination, on human bladder tumor xenografts in nude mice.
Hubbell HR; Kvalnes-Krick K; Carter WA; Strayer DR
Cancer Res; 1985 Jun; 45(6):2481-6. PubMed ID: 3986788
[TBL] [Abstract][Full Text] [Related]
29. Induction of high-grade, high-stage carcinomas in the rat urinary bladder.
Oyasu R; Samma S; Ozono S; Bauer K; Wallemark CB; Homma Y
Cancer; 1987 Feb; 59(3):451-8. PubMed ID: 3791155
[TBL] [Abstract][Full Text] [Related]
30. Reduction of bladder cancer growth in mice treated with intravesical Bacillus Calmette Guerin and systemic interleukin 2.
Lee KE; Weiss GH; O'Donnell RW; Cockett AT
J Urol; 1987 Jun; 137(6):1270-3. PubMed ID: 3495671
[TBL] [Abstract][Full Text] [Related]
31. Requirement of a thymus dependent immune response for BCG-mediated antitumor activity.
Ratliff TL; Gillen D; Catalona WJ
J Urol; 1987 Jan; 137(1):155-8. PubMed ID: 3491909
[TBL] [Abstract][Full Text] [Related]
32. Bladder cancer xenografts: a model of tumor cell heterogeneity.
Russell PJ; Raghavan D; Gregory P; Philips J; Wills EJ; Jelbart M; Wass J; Zbroja RA; Vincent PC
Cancer Res; 1986 Apr; 46(4 Pt 2):2035-40. PubMed ID: 2418959
[TBL] [Abstract][Full Text] [Related]
33. Squamous and transitional elements in rat bladder carcinomas induced by N-butyl-N-4-hydroxybutyl-nitrosamine (BBN). A study of cytokeratin expression.
Herman CJ; Vegt PD; Debruyne FM; Vooijs GP; Ramaekers FC
Am J Pathol; 1985 Sep; 120(3):419-26. PubMed ID: 2412446
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy and human bladder carcinoma transplanted into NMRI nu/nu mice.
Huland H; Otto U; von Paleske A
J Urol; 1985 Sep; 134(3):601-6. PubMed ID: 2411953
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the fibronectin-binding ability and antitumor efficacy of various mycobacteria.
Hudson MA; Ritchey JK; Catalona WJ; Brown EJ; Ratliff TL
Cancer Res; 1990 Jul; 50(13):3843-7. PubMed ID: 2191767
[TBL] [Abstract][Full Text] [Related]
36. Magnetic resonance imaging for detecting and treatment monitoring of orthotopic murine bladder tumor implants.
Chin J; Kadhim S; Garcia B; Kim YS; Karlik S
J Urol; 1991 Jun; 145(6):1297-301. PubMed ID: 2033720
[TBL] [Abstract][Full Text] [Related]
37. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors.
Janik P; Briand P; Hartmann NR
Cancer Res; 1975 Dec; 35(12):3698-704. PubMed ID: 1192428
[TBL] [Abstract][Full Text] [Related]
38. Single and combination chemotherapy for primary murine bladder cancer.
Soloway MS
Cancer; 1975 Aug; 36(2):333-40. PubMed ID: 1157004
[TBL] [Abstract][Full Text] [Related]
39. Experimental bladder tumor induction, propagation, and therapy.
Williams PD; Murphy GP
Urology; 1976 Jul; 8(1):39-42. PubMed ID: 941358
[TBL] [Abstract][Full Text] [Related]
40. Intravesical and systemic chemotherapy of murine bladder cancer.
Soloway MS
Cancer Res; 1977 Aug; 37(8 Pt 2):2918-29. PubMed ID: 406041
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
